Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid
- PMID: 1691925
- DOI: 10.1016/0006-3223(90)90470-m
Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid
Abstract
Concentrations of HVA, 5-HIAA, ascorbic acid, and uric acid in the lumbar and cisternal cerebrospinal fluid (CSF) were measured in psychiatric and neurologically impaired patients. The concentration of HVA is 6.1 times and of 5-HIAA 2.7 times higher in cisternal than in lumbar samples, the cisternal level of uric acid is half that of the lumbar region, but no significant differences were found in ascorbic acid concentrations. Correlation between lumbar and cisternal metabolite concentrations is high for 5-HIAA and ascorbic acid, and is less for HVA and uric acid. In cisternal CSF there is a significant correlation between levels of HVA-5-HIAA, 5-HIAA-ascorbic acid, and 5-HIAA-uric acid. These correlations disappear in lumbar CSF. These findings indicate that extrapolations to cisternal neurotransmitter metabolite concentration from lumbar measures are unwarranted for HVA, but not for 5-HIAA.
Similar articles
-
Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid.Acta Neurol Scand. 1975 Aug;52(2):137-44. doi: 10.1111/j.1600-0404.1975.tb05767.x. Acta Neurol Scand. 1975. PMID: 1155031
-
Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.Biol Psychiatry. 1990 May 15;27(10):1179-82. doi: 10.1016/0006-3223(90)90055-7. Biol Psychiatry. 1990. PMID: 1692743 No abstract available.
-
Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.Neuropsychopharmacology. 1992 Dec;7(4):295-304. Neuropsychopharmacology. 1992. PMID: 1282317
-
The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.Neuropsychopharmacology. 2001 Oct;25(4):468-75. doi: 10.1016/S0893-133X(01)00250-0. Neuropsychopharmacology. 2001. PMID: 11557160 Clinical Trial.
-
Factors governing the composition of the cerebrospinal fluid.Exp Eye Res. 1977;25 Suppl:205-28. doi: 10.1016/s0014-4835(77)80019-5. Exp Eye Res. 1977. PMID: 338318 Review. No abstract available.
Cited by
-
Targeted and Non-Targeted Metabolomic Evaluation of Cerebrospinal Fluid in Early Phase Schizophrenia: A Pilot Study from the Hopkins First Episode Psychosis Project.Metabolites. 2025 Apr 15;15(4):275. doi: 10.3390/metabo15040275. Metabolites. 2025. PMID: 40278404 Free PMC article.
-
Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.Front Cell Neurosci. 2013 Jun 11;7:90. doi: 10.3389/fncel.2013.00090. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23781173 Free PMC article.
-
Intrathecal therapy for chronic pain: current trends and future needs.Curr Pain Headache Rep. 2014 Jan;18(1):388. doi: 10.1007/s11916-013-0388-x. Curr Pain Headache Rep. 2014. PMID: 24338701 Review.
-
Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs.Pharm Res. 2022 Jul;39(7):1393-1413. doi: 10.1007/s11095-022-03275-1. Epub 2022 Apr 29. Pharm Res. 2022. PMID: 35488144
-
Preference for novel faces in male infant monkeys predicts cerebrospinal fluid oxytocin concentrations later in life.Sci Rep. 2017 Oct 11;7(1):12935. doi: 10.1038/s41598-017-13109-5. Sci Rep. 2017. PMID: 29021623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical